National Institutes Of Health Examines Allergic Reactions To COVID-19 Vaccines

Published on:

Apr 08, 2021, 00:20

Updated on:

Apr 08, 2021, 00:20

The U.S. National Institutes of Health (NIH) announced Wednesday a clinical trial was underway to determine the risk of allergic reactions to the COVID-19 vaccines manufactured by Moderna and Pfizer.

A press release from the National Institutes of Health says the trial will determine whether people are highly allergic to the vaccine or have a disorder that puts them at an increased risk for an immediate, systemic allergic reaction to the vaccine.

Follow NewsGram on Instagram to keep yourself updated.

While the vaccines are considered safe, several rare allergic reaction incidents — including serious episodes, known as anaphylaxis — have been reported in the U.S. after Pfizer-BioNTech and Moderna shots were given.

The advantages of the COVID-19 vaccination greatly outweigh the disadvantages. Pixabay

The trial will also examine the biological mechanism behind allergic reactions in the body and whether a certain genetic pattern or other factors can be used to predict high-risk recipients.

"The information gathered during this trial will help doctors advise people who are highly allergic or have a mast cell disorder about the risks and benefits of receiving these two vaccines. However, for most people, the benefits of COVID-19 vaccination far outweigh the risks," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, said in the statement.

NIH says a mast cell disorder is a disease caused by a type of white blood cell called a mast cell that is abnormal, overly active, or both, predisposing a person to life-threatening reactions.

The Phase 2 trial, called Systemic Allergic Reactions to SARS-CoV-2 Vaccination, is sponsored and funded by NIAID.

ALSO READ: Post-COVID World Requires Equitable Healthcare access: World Health Organization

The vaccines used in the trial are provided by the program led by the U.S. Department of Health and Human Services and the U.S. Department of Defense that develops COVID-19 vaccines and therapeutics.

The study will include 3,400 adults ages 18 to 69 at up to 35 academic allergy research centers nationwide. (VOA/KB)

<h1>Courses/Internships at NewsGram</h1>

<p> At <strong>NewsGram</strong> , we believe in the power of truthful Journalism and our Newsroom is always striving for a meaningful, engaging and fact based reporting.</p>

<p>You can become the part of NewsGram's dynamic newsroom with Certification Programs and Internships. Here are the details:</p>

<hr>

<h2>NewsGram Journalism Certification Program</h2>

<p><strong>Duration:</strong> 8 Weeks (Remote/Part-time)</p>

<p><strong>For:</strong> Journalism, Media, Communications, and Social Sciences Students and Professionals, with a strong interest in current affairs, politics, and culture.</p>

<h3>Program Highlights:</h3>

<ul>

<li>Fundamentals of Ethical Journalism</li>

<li>News Writing and Reporting</li>

<li>Rewriting Current News Stories (Rehashing)</li>

<li>Social Media Management for News</li>

<li>SEO and Content Management System (CMS) Training</li>

<li>Interviewing Experts and Sources</li>

<li>Fact-Checking and Ethical Reporting Practices</li>

</ul>

<ul>

<li>Write News articles and rehash existing stories</li>

<li>Edit and publish news content on NewsGram’s platform</li>

<li>Manage social media posts to promote NewsGram’s content</li>

<li>Conduct interviews with experts or key figures</li>

<li>Learn to use CMS for publishing articles</li>

<li>Participate in editorial projects like <em>Long Read</em>, <em>Live Stories</em>, and <em>MediaSight</em></li>

</ul>

<h3>Benefits:</h3>

<ul>

<li>Author profile with lifetime access on NewsGram</li>

<li>Certificate of Completion</li>

<li>1:1 Mentorship with experienced Journalists</li>

<li>Weekend live sessions for training and feedback</li>

<li>Access to article performance analytics and SEO reports</li>

<li>Opportunity to transition into freelance or full-time roles with NewsGram</li>

</ul>

<style>

.tab-container {

margin-top: 20px;

}

.tab-button {

background-color: #af0000;

color: #fff;

border: none;

cursor: pointer;

padding: 12px 18px;

margin: 2px;

font-weight: 600;

font-size: 15px;

border-radius: 4px;

transition: background-color 0.3s ease;

}

.tab-button:hover,

.tab-button.active {

background-color: #000000;

}

u8i

.tab-content {

display: none;

padding: 15px;

border: 1px solid #000000;

border-top: none;

background-color: #af0000;

font-size: 15px;

line-height: 1.6;

}

.tab-content h4 {

margin-top: 0;

color: #222;

}

.tab-content ul {

padding-left: 20px;

}

</style>

<h3>Curriculum Details:</h3>

<button class="tab-button" onclick="showTab('module1')">Module 1: Foundations</button>

<button class="tab-button" onclick="showTab('module2')">Module 2: Writing</button>

<button class="tab-button" onclick="showTab('module3')">Module 3: CMS</button>

<button class="tab-button" onclick="showTab('module4')">Module 4: SEO</button>

<button class="tab-button" onclick="showTab('module5')">Module 5: Digital Media</button>

<button class="tab-button" onclick="showTab('module6')">Module 6: Analytics</button>

<button class="tab-button" onclick="showTab('module7')">Module 7: AI Tools</button>

<h4>Module 1: Foundations of Journalism</h4>

<ul>

<li>What is Journalism?</li>

<li>Types of Articles: News Reports, Syndicated Stories, Interviews, Investigative Stories, Coverings Beats and Opinions Pieces</li>

<li>Rewriting techniques and ethical considerations</li>

<li>Interviewing clinicians and experts</li>

</ul>

</div>

<h4>Module 2: News Writing techniques and Content Structure </h4>

<ul>

<li>Writing tone, structure & language for general audiences</li>

<li>Paraphrasing, quoting, and avoiding plagiarism</li>

<li>Using images and referencing styles (Chicago, AP, etc.)</li>

</ul>

</div>

<h4>Module 3: CMS and Publishing Process</h4>

<ul>

<li>Introduction to platforms like Quintype</li>

<li>Formatting, metadata, tagging, article scheduling</li>

<li>Handling media and embedded content</li>

</ul>

</div>

<h4>Module 4: SEO Essentials for Medical Content</h4>

<ul>

<li>What is SEO? Importance in Digital News Content</li>

<li>On-page SEO: Titles, meta descriptions, slugs</li>

<li>Readability, mobile optimization, keyword strategy</li>

</ul>

</div>

<h4>Module 5: Digital Media and Monetization Models</h4>

<ul>

<li>Digital-first vs traditional journalism</li>

<li>CMS platforms and editorial workflows</li>

<li>Introduction to paywalls and subscription models</li>

</ul>

</div>

<h4>Module 6: Analytics, Google Tools & Authority Metrics</h4>

<ul>

<li>Google Analytics (GA4) & traffic data</li>

<li>Search Console for Indexing and Performance</li>

<li>Understanding DA, Page authority, and Site Trust</li>

</ul>

</div>

<h4>Module 7: AI in Medical Journalism</h4>

<ul>

<li>Using AI tools for writing, grammar, and summarizing</li>

<li>Transcription & reader personalization with AI</li>

<li>Ethical use of AI the Newsroom</li>

</ul>

</div>

function showTab(id) {

const tabs = document.querySelectorAll(".tab-content");

const buttons = document.querySelectorAll(".tab-button");

tabs.forEach(tab => tab.style.display = "none");

buttons.forEach(btn => btn.classList.remove("active"));

document.getElementById(id).style.display = "block";

event.target.classList.add("active");

}

document.addEventListener("DOMContentLoaded", () => {

document.querySelector(".tab-button").click();

});

</script>

<hr>

<h3>📬 How to Apply:</h3>

<p>Please send your resume to: <strong><a href="mailto:internship@newsgram.com">internship@newsgram.com</a></strong></p>

<h3>👨‍🏫 Faculty & Mentorship Team</h3>

<style>

.faculty-scroll {

display: flex;

overflow-x: auto;

gap: 30px;

padding: 20px 0;

scrollbar-width: thin;

}

.faculty-card {

flex: 0 0 auto;

width: 280px;

background-color: #af0000;

border-radius: 20px;

box-shadow: 0 4px 20px rgba(0,0,0,0.1);

text-align: center;

padding: 20px;

transition: transform 0.3s;

}

.faculty-card:hover {

transform: translateY(-5px);

}

.faculty-card img {

width: 200px;

height: 200px;

object-fit: cover;

border-radius: 50%;

margin-bottom: 15px;

border: 4px solid #000000;

}

.faculty-card a {

font-weight: bold;

text-decoration: none;

color: #fff;

font-size: 18px;

}

.faculty-card span {

font-size: 15px;

color: #fff;

display: block;

margin-top: 6px;

}

</style>

<a href="https://www.linkedin.com/in/munishraizada/" target="_blank">Dr. Munish Kumar Raizada, MD, FAAP</a>

<span style="display:block;">Editor-in-Chief, NewsGram INC</span>

</div>

<a href="https://www.linkedin.com/in/himani-negi-7a9537215/" target="_blank">Himani Negi, B Pharmacy</a>

<span style="display:block;">Contributing Editor, NewsGram</span>

</div>

<a href="https://www.linkedin.com/in/subhamahes98/" target="_blank">M Subha Maheswari, MSc Biotechnology</a>

<span style="display:block;">Contributing Editor, NewsGram</span>

</div>

<a href="https://www.linkedin.com/in/dr-theresa-lily-thomas-4613ab290/" target="_blank">Dr. Theresa Lily Thomas, BDS</a>

<span style="display:block;">Content Lead, NewsGram Desk</span>

</div>

<a href="https://www.linkedin.com/in/-ritik-singh/" target="_blank">Ritik Singh, Bachelors in Journalism </a>

<span style="display:block;">Desk Editor</span>

</div>

covid-19

vaccine

moderna

covid-19 vaccination

National Institute of Allergy and Infectious Diseases

the U.S.

Pfizer-BioNTech

Allergic reactions

Department of Defense

SARS-CoV-2 Vaccination

National Institutes Of Health Examines Allergic Reactions To COVID-19 Vaccines

Related Stories